Atom Investors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,253
Closed -$244K – 1035
2026
Q2
$244K Buy
+1,253
New +$260K 0.02% 731
2024
Q1
– Sell
-2,009
Closed -$346K – 657
2023
Q4
$346K Sell
2,009
-1,826
-48% -$281K 0.06% 339
2023
Q3
$567K Buy
+3,835
New +$693K 0.13% 210
2020
Q4
– Sell
-4,576
Closed -$784K – 536
2020
Q3
$784K Buy
+4,576
New +$845K 0.07% 218
2019
Q4
– Sell
-2,307
Closed -$312K – 297
2019
Q3
$312K Sell
2,307
-699
-23% -$91.6K 0.02% 241
2019
Q2
$367K Sell
3,006
-10,597
-78% -$1.17M 0.02% 327
2019
Q1
$1.41M Buy
+13,603
New +$1.4M 0.12% 153

Other funds holding RMD

Atom Investors's RMD Position: Q3 2026 in Review

Atom Investors sold out of ResMed (RMD) in Q3 2026, closing a stake of 1,253 shares — an estimated $244K sold.

Atom Investors first reported a position in RMD in Q1 2019 and held it in 7 quarters. The position peaked at $1.41M in Q1 2019. 860 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Atom Investors reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • Atom Investors sold 1,253 ResMed shares in Q3 2026, an estimated $244K.
  • Atom Investors first reported a position in ResMed in Q1 2019 and held it in 7 quarters.
  • Atom Investors's ResMed position peaked at $1.41M in Q1 2019.
  • 860 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.